StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.12+0.00 (0.00%)

Close on Nov 17, 2026Market cap $92.08MP/E –Yield –

Research Alliance Corp III total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Research Alliance Corp III

Research Alliance Corp III has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Research Alliance Corp III figures

See a number that looks wrong?